Journal of Biomolecular Research Therapeutics

About the Journal

In our rapidly evolving and complex world, understanding the molecular foundations of human health and disease has become more critical than ever. The intricate biological mechanisms that govern our physiology and pathology constantly challenge the boundaries of biomedical science. As living systems adapt to environmental changes, they exhibit a multifaceted interplay of biochemical, genetic, and cellular processes. Biomolecular research, a vital domain within biomedical and life sciences, plays a central role in decoding these fundamental aspects.

This field extensively investigates key areas such as molecular biology, genomics, proteomics, bioinformatics, pharmacogenomics, enzyme activity, signal transduction, and cellular pathways that underlie both normal function and pathological states. These topics are explored across various research paradigms including molecular medicine, translational science, pharmacology, biotechnology, and systems biology. A deeper understanding in these areas enhances our ability to innovate in diagnostics, therapeutics, and disease prevention.

The Journal of Biomolecular Research & Therapeutics offers an open-access platform for students, researchers, and professionals working in or interested in molecular and therapeutic research. It welcomes scholarly contributions across a wide spectrum of biomedical science, including molecular mechanisms of disease, drug development, biotherapeutics, cancer biology, biomarker discovery, metabolic disorders, nanomedicine, and regenerative medicine.

Researchers in biomolecular science are encouraged to submit original, impactful work to this journal, which promotes the dissemination of pioneering research across the biomedical and therapeutic sciences. Peer-reviewed publications in this field serve as vital resources for both academic and clinical communities.

Timely publication and open scientific dialogue are essential for advancing knowledge and fostering innovation. The Journal of Biomolecular Research & Therapeutics, a high-impact publication, ensures rapid and unbiased peer review to support fast, open access to new findings that benefit the global scientific and medical community.

The journal employs an Online Submission System to facilitate streamlined manuscript tracking and review, similar to leading open-access journals. Manuscripts are reviewed by editorial board members or expert reviewers, with acceptance requiring approval from at least two reviewers and the editor.

Authors are requested to submit manuscripts online at Submit Manuscript or Send as an e-mail attachment to the Editorial Office at editor@globalmeetx.net

Rapid Publication Service

Globalmeetx Publishing is offering wide range of opportunities, options and services for the prospective authors to publish their scholarly contributions.

The journal caters to the demands of the fast publication without compromising on the editorial quality including manuscript peer-review. This flexibility is being provided to ensure earliest author credibility to their respective contributions and this will also ensure timely dissemination of research outcomes for efficient integration, effective translation and reduced redundancy.

Authors have the option to choose between the standard open access publication service which takes its own course of time for complete publication process or can opt for rapid publication service wherein the article is published at the earliest date (Includes multiple subject experts commissioning for securing earliest peer-review comments). The authors can avail this flexibility based on the personal preference, funding agency guidelines or Institutional or organizational requirements.

Regardless of the option, all manuscripts undergo thorough peer-review process, editorial assessment and production process.

Fast Editorial Execution and Review Process (FEE-Review Process)

Authors who are willing to publish their articles under this mode can make a pre-payment of $99 towards express peer-review and editorial decision. First editorial decision in 3 days and final decision with review comments in 5 days from the date of submission. Galley proof generation will be done in next 2 days from acceptance or maximum 5 days (For manuscripts notified for revision by external reviewer).

Manuscripts accepted for publication will be charged regular APC.

Authors retain the copyright of their publication and the final version of the article will be published in both HTML and PDF formats as well as XML formats for transmitting to indexing databases. The editorial team of the Journal will ensure adherence to scientific publication guidelines.